bc-ontologyGovernments, institutions, geography and law
Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

21 U.S.C. 360n-1 Priority review for qualified infectious disease products

21 U.S.C. 360n-1 Priority review for qualified infectious disease products, “Priority review for qualified infectious disease products”, is a U.S. Code section of Part A—Drugs and Devices; in force.

https://ontology.bommaritollc.com/id/01a0f06c-cd1a-71cb-a82f-2a31a0f57ae0
schema:Legislation
Download TurtleJSON-LDN-TriplesMarkdown
Cite this
21 U.S.C. 360n-1 Priority review for qualified infectious disease products. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-cd1a-71cb-a82f-2a31a0f57ae0

Elsewhere

Facts

adms:identifier
eli:cites
prov:wasDerivedFrom
schema:isPartOf
schema:legislationIdentifier
21 U.S.C. 360n-1
schema:legislationJurisdiction
schema:legislationLegalForce
schema:legislationType
schema:name
Priority review for qualified infectious disease productsen
schema:url
skos:prefLabel
21 U.S.C. 360n-1 Priority review for qualified infectious disease productsen

Related

Rules made under it (16)eli:based_on

Amended by (2)eli:amends

Cited by (1)eli:cites

Its changes, from (1)eli:changes